We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PEN market cap is 7.91B. The company's latest EPS is USD 2.3500 and P/E is 86.97.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 213.68M | 221.22M | 241.4M | 261.5M | 270.95M |
| Operating Income | 5.43M | 4.83M | 8.01M | 17.89M | 12.63M |
| Net Income | -2.27M | 3.88M | 8.56M | 18.96M | 9.21M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 547.41M | 560.41M | 747.59M | 847.13M | 1.06B |
| Operating Income | 47.51M | -38.94M | -7.5M | 6.08M | 73.55M |
| Net Income | 48.46M | -15.7M | 5.28M | -2M | 90.95M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.32B | 1.37B | 1.4B | 1.43B | 1.47B |
| Total Liabilities | 347.85M | 372.03M | 370.83M | 365.99M | 364.24M |
| Total Equity | 973.75M | 998.86M | 1.02B | 1.07B | 1.1B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 665.9M | 822.98M | 1.24B | 1.37B | 1.56B |
| Total Liabilities | 180.29M | 185.2M | 290.32M | 372.03M | 377.36M |
| Total Equity | 485.61M | 637.79M | 953.93M | 998.86M | 1.18B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -57M | -55.66M | 13.13M | 30.23M | 61.07M |
| Investing | 46.16M | 54.79M | 10.71M | 4.04M | -40.36M |
| Financing | 5.89M | 11.62M | 1.38M | 10.07M | 10.28M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 26.65M | -33.24M | 9.5M | -55.66M | 97.33M |
| Investing | -12.71M | -104.15M | -21.74M | 54.79M | -16.08M |
| Financing | -8.96M | 134.92M | 836k | 11.62M | 16.2M |
| Market Cap | 7.91B |
| Price to Earnings Ratio | 86.97 |
| Price to Sales Ratio | 7.47 |
| Price to Cash Ratio | 47.23 |
| Price to Book Ratio | 6.71 |
| Dividend Yield | - |
| Shares Outstanding | 38.7M |
| Average Volume (1 week) | 335.17k |
| Average Volume (1 Month) | 294.07k |
| 52 Week Change | -28.11% |
| 52 Week High | 348.67 |
| 52 Week Low | 180.93 |
| Spread (Intraday) | 17 (7.91%) |
| Company Name | Penumbra Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.penumbrainc.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
